No Data
No Data
Investors Shouldn't Be Too Comfortable With Youngy Health's (SZSE:300247) Earnings
Rongjie Health: 2024 Semi-Annual Report Summary
Rongjie Health: 2024 Semi-Annual Report
Youngy Health (300247.SZ) released its semi-annual performance report with a net income of 28.6764 million yuan, a year-on-year increase of 36.30%.
Youngy Health (300247.SZ) disclosed its semi-annual report for 2024, with revenue reaching 3...
As of July 31, 2024, there were 32,332 shareholders of Youngy Health (300247.SZ).
Youngy Health (300247.SZ) stated on the investor interaction platform on August 7 that as of July 31, 2024, the number of company shareholders is 32,332.
Youngy Health (300247.SZ) does not have any business related to cell therapy.
Youngy Health (300247.SZ) stated on their investor platform on August 7th that they currently do not have any related business in cellular therapy.
No Data
No Data